DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/58235a/ghana_pharmaceutic) has announced the addition of the "Ghana Pharmaceuticals and Healthcare Report Q1 2011" report to their offering.
The Ghana Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Ghana's pharmaceuticals and healthcare industry.
Ghana's healthcare system is rapidly becoming a centre of excellence in West Africa. Furthermore, its pharmaceutical industry is attracting interest from foreign investors ahead of its neighbour Nigeria, as a potential entry point into the regional market. The National Health Insurance Scheme (NHIS), introduced in 2003-04 has had mixed success thus far, but more recently has been improving its standards, receiving plaudits from across Africa and non-governmental organisations.
In 2009 total pharmaceutical sales were GSH456mn (US$319mn). Market share is split quite evenly between patented drugs, generic drugs and over-the-counter (OTC) medicines, but due to the levels of wealth inequality across the population, pharmaceutical demand is predominantly influenced by drug pricing. Although, many pharmacists continue to purchase medicines from more expensive private sources, as foreign medications continue to be regarded as superior.
Key Topics Covered:
- Executive Summary
- SWOT Analysis
- Pharmaceutical Business Environment Ratings
- Ghana - Market Summary
- Regulatory Regime
- Industry Developments
- Industry Forecast Scenario
- Competitive Landscape
- Company Profiles
- Methodology
Companies Mentioned:
- LaGray Chemical Company
- Historical D
- DanAdams Pharmaceutical Industry
For more information visit http://www.researchandmarkets.com/research/58235a/ghana_pharmaceutic.